ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
2 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Ganbaatar
|
218 |
77K |
2 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
218
|
77K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
4 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Ganbaatar
|
115 |
60K |
7 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
115
|
60K
|
7
|
|
ASX - By Stock
|
VVA |
Re:
Ann: Ord Minnett Leisure, Tourism & Gaming Conference Presentatio
|
|
Ganbaatar
|
3 |
1.1K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
0 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
VVA |
Re:
Ann: Viva Leisure expands wellness offering with acquisition
|
|
Ganbaatar
|
6 |
2.2K |
2 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
6
|
2.2K
|
2
|
|
ASX - By Stock
|
MFG |
Re:
Undervalued & technically oversold
|
|
Ganbaatar
|
250 |
92K |
1 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
250
|
92K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
0 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
339
|
141K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
5 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
339
|
141K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
0 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
339
|
141K
|
0
|
|
ASX - By Stock
|
KGN |
Re:
Ann: Domain sale re Bitbuy
|
|
Ganbaatar
|
28 |
13K |
4 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
28
|
13K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
11 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
339
|
141K
|
11
|
|
ASX - By Stock
|
KGN |
Re:
Ann: October 2021 Business Update
|
|
Ganbaatar
|
47 |
19K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
47
|
19K
|
0
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Ganbaatar
|
26 |
13K |
1 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
26
|
13K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
21 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
339
|
141K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Ganbaatar
|
339 |
141K |
25 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
339
|
141K
|
25
|
|
ASX - By Stock
|
PAR |
Re:
Blue Ocean Valuation
|
|
Ganbaatar
|
22 |
9.4K |
2 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
22
|
9.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Ganbaatar
|
191 |
77K |
18 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
191
|
77K
|
18
|
|
ASX - By Stock
|
KGN |
Re:
why-the-kogan-asxkgn-share-price-could-be-a-top-buy
|
|
Ganbaatar
|
40 |
15K |
8 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
40
|
15K
|
8
|
|
ASX - By Stock
|
KGN Education |
Re:
Kogan, why is it one of the most shorted stocks in AU?
|
|
Ganbaatar
|
51 |
75K |
9 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
51
|
75K
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip signs agreement with Microsoft
|
|
Ganbaatar
|
315 |
109K |
2 |
01/10/21 |
01/10/21 |
ASX - By Stock
|
315
|
109K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Zip signs agreement with Microsoft
|
|
Ganbaatar
|
315 |
109K |
18 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
315
|
109K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Ganbaatar
|
294 |
119K |
7 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
294
|
119K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
0 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Sass
|
|
Ganbaatar
|
82 |
26K |
5 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
82
|
26K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: CHIKV study data published in Peer-Reviewed Journal
|
|
Ganbaatar
|
24 |
9.0K |
8 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
24
|
9.0K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: CHIKV study data published in Peer-Reviewed Journal
|
|
Ganbaatar
|
24 |
9.0K |
1 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
24
|
9.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Sass
|
|
Ganbaatar
|
82 |
26K |
7 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
82
|
26K
|
7
|
|
ASX - By Stock
|
VVA |
Re:
VVA and COVID-19 Restrictions
|
|
Ganbaatar
|
9 |
3.4K |
1 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
9
|
3.4K
|
1
|
|
ASX - By Stock
|
VVA |
Re:
VVA and COVID-19 Restrictions
|
|
Ganbaatar
|
9 |
3.4K |
1 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
9
|
3.4K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2021 Annual Report and Appendix 4E
|
|
Ganbaatar
|
82 |
31K |
6 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
82
|
31K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2021 Annual Report and Appendix 4E
|
|
Ganbaatar
|
82 |
31K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
82
|
31K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
0 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
VVA |
Re:
VVA and COVID-19 Restrictions
|
|
Ganbaatar
|
9 |
3.4K |
2 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
9
|
3.4K
|
2
|
|
ASX - By Stock
|
VVA |
VVA and COVID-19 Restrictions
|
|
Ganbaatar
|
9 |
3.4K |
2 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
9
|
3.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2021 Annual Report and Appendix 4E
|
|
Ganbaatar
|
82 |
31K |
6 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
82
|
31K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2021 Annual Report and Appendix 4E
|
|
Ganbaatar
|
82 |
31K |
5 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
82
|
31K
|
5
|
|
ASX - By Stock
|
VVA |
Re:
Ann: Trading Halt
|
|
Ganbaatar
|
9 |
3.4K |
0 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
9
|
3.4K
|
0
|
|
ASX - By Stock
|
VVA |
Re:
Ann: Trading Halt
|
|
Ganbaatar
|
9 |
3.4K |
0 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
9
|
3.4K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: FY21 Results - Transformational Year as Zip Goes Global
|
|
Ganbaatar
|
121 |
47K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
121
|
47K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: FY21 Results - Transformational Year as Zip Goes Global
|
|
Ganbaatar
|
121 |
47K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
121
|
47K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
1 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
1 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
16 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
2 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
2 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
0 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Ganbaatar
|
4.4K |
2.0M |
1 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|